Skip to main content

Assessment of the influence of citrate concentration on the International Normalized Ratio (INR) determined with twelve reagent-instrument combinations.

Chantarangkul V, Tripodi A, Clerici M, Negri B, Mannucci PM

Publication: Thromb Haemost (1998) • Vol 80 • Page 258-62PMID: 9716149View on PubMed

Purpose

The purpose of this paper was to determine the effects of citrate concentration and instrument/reagent combination on prothrombin time (PT) in plasma specimens.

Conclusion

Mean PTs were longer for specimens collected in tubes containing 129 mM citrate compared to those collected in tubes containing 105 mM citrate, regardless of instrument, thromboplastin reagent, or whether the specimen was from a healthy volunteer or a patient on oral anticoagulant therapy. There were significant differences in the PT ratios (patient PT/mean PT of 20 normal volunteers) between the two citrate concentrations for many instrument/reagent combinations. The International Sensitivity Index (ISI) values were generally greater when calibration was done using specimens collected in tubes containing 105 mM citrate rather than 129 mM citrate. The importance of using the appropriate ISI value to calculate the International Normalized Ratio (INR) value (i.e. ISI-105 to calculate INR-105 or ISI-manual to calculate INR-manual) is demonstrated, as inappropriate ISI values led to significant differences in INR values.

Studies (1)

Purpose

The purpose of this study was to determine the effects of trisodium citrate concentration and instrument/reagent combination on PT in plasma specimens from normal volunteers and patients on oral anticoagulant therapy.

Summary of Findings

Mean PTs were longer for specimens collected in tubes containing 129 mM citrate compared to those collected in tubes containing 105 mM citrate, regardless of instrument, thromboplastin reagent, or whether the specimen was from a healthy volunteer or a patient on oral anticoagulant therapy, although the range of percentage differences was larger for patients on oral anticoagulant therapy than healthy volunteers. There were significant differences in the PT ratios (patient PT/mean PT of 20 normal volunteers) between the two citrate concentrations for the following instrument/reagent combinations: manual/Innovin, manual/PT HS, ACL 300R/ Recombiplastin, ACL 300R/Innovin, ACL 300R/PT HS, Koagulab/Neoplastin plus, Koagulab/Innovin, and Koagulab/PT HS. The other instrument/reagent combinations did not result in significant differences in PT ratios between the two citrate concentrations. For the BCT/441 reagent used only with the manual tilt tube technique, the ISI was not significantly influenced by citrate concentration, however, for the other 4 reagents, ISI values were greater when calibration was done using specimens collected in 105 mM citrate rather than 129 mM citrate, and the largest differences were observed for Innovin and PT HS, regardless of technique/instrument. Using the inappropriate ISI value to calculate INR values (i.e. ISI-105 to calculate INR-129) rather than the appropriate ISI led to significantly different INR values, which were clinically significant for specimens with an INR of 4.5 for all instrument/reagent combinations tested. Further, the effects of citrate concentration were even more pronounced if the ISI generated with the manual technique was used to determine INR values using the 4 instruments.

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Normal
    Not specified
  • Platforms

    MorphologyHematology/ auto analyzer
    MorphologyMacroscopic observation
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionOther drugs
    None
    Oral anticoagulant therapy
    Biospecimen AcquisitionAnticoagulant
    Multiple concentrations evaluated
    Sodium citrate
    Macroscopic observation SpecificReaction solution
    BCT/441
    Innovin
    Neoplastin plus
    PT HS
    Recombiplastin
    Hematology/ auto analyzer SpecificReaction solution
    Innovin
    Neoplastin plus
    PT HS
    Recombiplastin
    Hematology/ auto analyzer SpecificTechnology platform
    ACL 300R
    Koagulab Chromo
    Manual tilt tube technique